The Company today reached a strategic milestone in its commercialisation pathway for PromarkerD,...
Proteomics Commences Therapeutic Drug Discovery Program
The Company is pleased to announce that it has commenced a Therapeutic Drug Discovery program utilising its proprietary proteomics-based technology platform.